摘要
目的:研究脑啡肽乙酸酯( DADLE)是否通过调控胞外信号调控激酶( ERK)信号转导通路而抑制大鼠急性全脑缺血-再灌注后海马区神经细胞凋亡。方法健康雌性SD大鼠50只(180~220 g)随机分为五组,建立大鼠急性全脑缺血-再灌注模型:假手术组( Sham组,n=10),只行手术分离血管,不予结扎血管及再灌注;缺血-再灌注组(I/R组,n=10),缺血15 min,再灌注120 min;DADLE+PD98059组(DA+PD组,n=10),缺血15 min后再灌注开始前静脉注射DADLE(3 mg/kg)及PD98059(0.3 mg/kg),然后行再灌注120 min; PD98059组(PD组,n=10),缺血15 min后再灌注开始前静脉注射PD98059(0.3 mg/kg);DADLE处理组(DA组,n=10),缺血15 min后再灌注开始前静脉注射DADLE(3 mg/kg),然后行再灌注120 min。 HE染色观察各组海马CA1区神经元病理变化情况,TUNEL法检测大鼠海马凋亡细胞,Western blot检测脑组织磷酸化ERK1/2(P-ERK1/2)的表达状况。结果 HE染色显示,I/R组、DA+PD组、PD组、DA组较Sham组正常神经元细胞计数显著减少(P<0.01);DA组神经元的损伤、脱失、细胞肿胀均较I/R组轻,正常神经元细胞计数较I/R组显著增多(P<0.01);PD组、DA+PD组及I/R组正常神经元细胞计数组间两两比较差异无统计学意义。 TUNEL法检测显示,I/R组、DA+PD组、PD组、DA组大鼠海马CA1区神经细胞凋亡指数均较Sham组显著升高(P<0.01);与I/R组比较,DA+PD组及DA组凋亡指数显著下降(P<0.01),PD组凋亡指数则升高(P<0.05);DA+PD组、PD组及DA组组间两两比较差异有统计学意义( P<0.01)。Western blot检测显示,I/R组(0.69±0.07)、DA+PD组(0.59±0.03)及DA组(0.83±0.06)的P-ERK1/2表达较Sham组(0.42±0.06)增多(P<0.01),而PD组(0.41±0.05)则无显著变化;PD组对P-ERK1表达呈完全抑制,予DADLE处理后P-ERK1表达则显著增加;与I/R组比较, P-ERK1/2在DA组的表达显著增加(P<0.01),而在DA+PD组及PD组则显著降低(P<0.01);DA+PD组、PD组及DA组组间两两比较差异有统计学意义( P<0.01)。结论 DADLE可通过激活ERK1/2信号转导通路特别是ERK1通路而发挥抑制急性全脑缺血-再灌注损伤诱导的神经细胞凋亡作用。
Objective To investigate whether DADLE could affect rat brain hippocampus neuronal apoptosis after acute global cerebral ischemia-reperfusion injury by regulating ERK signaling pathway.Methods Fifty female Sprague-Dawley rats (180 ~220 g) were randomly divided into 5 groups:sham group (Sham, n=10) exposed bilateral common artery but without occlusion;ischemia/reperfusion group ( I/R, n =10 ) was induced by bilateral common artery occlusion combined with hypotension for 15 min global ischemia followed by 120 min reperfusion; DADLE +PD98059 group (DA+PD, n=10), DADLE (3 mg/kg, iv) and PD98059 (0.3 mg/kg, iv) was applied through external jugular vein before reperfusion; PD98059 group (PD, n=10), PD98059 (0.3 mg/kg, iv) were applied through external jugular vein before reperfusion; DADLE group: DADLE (3 mg/kg, iv) was applied through external jugular vein before reperfusion. Neuropathological changes in rat hippocampus CA1 area were observed by Hernatoxylin-Eosin ( H-E) staining.Apoptotic cells in rat hippocampus were detected by TUNEL method, and the expression of phosphorylated ERK ( P-ERK) in rat brain tissue was assessed by immunoblotting.Results H -E staining demonstrated that the normal neurons in hippocampal CA1 area were significantly decreased in I/R, DA+PD, PD and DA group compared with that in Sham group (P〈0.01);and in DA group when compared with I/R group the normal neurons was remarkably increased (P〈0.01) with less neuronal damage, demyelination, cell swelling.But there were no significant difference of normal neurons counting among the PD, DA+PD and DADLE groups.TUNEL assay showed I/R group, DA +PD group, PD group, DA rat hippocampal CA1 neuronal apoptosis index was significantly higher than that in the Sham group ( P〈0.01);compared with I/R group, apoptotic index was significantly decreased (P〈0.01) in DA+PD and and DA group, but was increased (P〈0.05) in PD group;there were significant difference (P〈0.01) among DA +PD, PD and DA group.Western blotting showed that, compared with the sham group (0.42 ±0.06), the P -ERK1/2 expression in I/R group (0.69 ±0.07), DA +PD group (0.59 ±0.03) and the DA group (0.83 ±0.06) was increased (P〈0.01), while the PD group (0.41 ±0.05) showed no significant change; in PD group the P -ERK1 expression was completely suppressed, but P -ERK1 expression was increased significantly after treated by DADLE; compared with I/R group, P-ERK1/2 in the DA group was significantly increased ( P〈0.01), while in the DA+PD group and the PD group was significantly decreased ( P 〈0.01 ); the pairwise comparisons among DA +PD group, PD group and the DA group showed significant difference ( P 〈0.01 ) . Conclusion DADLE could inhibit acute global cerebral ischemia -reperfusion injury -induced neuronal apoptosis by activating ERK1/2 especially ERK1 signaling pathway.
出处
《中国急救医学》
CAS
CSCD
北大核心
2015年第6期539-543,I0002,共6页
Chinese Journal of Critical Care Medicine
基金
广州市医药卫生科技项目(201102A213152);2012年广东省临床重点专科基金